TL;DR
Quercetin is the most widely studied dietary flavonoid. It has been studied in published research for antioxidant and related pathways, including inflammation-related signaling, histamine pathways and cardiovascular research — provided for formulation context, not as product claims. The single biggest formulation challenge is bioavailability — raw quercetin aglycone is poorly absorbed, so most modern supplements use phytosomal or EMIQ forms. Bulk material is extracted commercially from Sophora japonica flower buds (10–25% native content) or recovered as a by-product of onion processing.
See our Quercetin product page for COA, grades, and bulk pricing.
Chemistry
- Systematic name: 3,3',4',5,7-pentahydroxyflavone
- CAS: 117-39-5
- Molecular formula: C₁₅H₁₀O₇
- Molecular weight: 302.24 g/mol
- Appearance: Yellow crystalline powder
Quercetin is a flavonol (3-hydroxy-flavone backbone). The position-3 hydroxyl differentiates it from luteolin and gives it the characteristic flavonol antioxidant profile.
Natural sources
| Plant | Latin | Form / part used | Typical content |
|---|---|---|---|
| Japanese pagoda tree | Sophora japonica | Flower bud | 10–25% (as rutin → hydrolyzed to quercetin) |
| Red onion | Allium cepa | Skin / outer scales | 1–4% (as glucosides) |
| Capers | Capparis spinosa | Fruit | ~180 mg/100 g |
| Apples | Malus domestica | Peel | 5–10 mg/100 g |
| Green tea | Camellia sinensis | Leaf | trace |
Commercial bulk quercetin almost always traces back to Sophora japonica flower bud, which is extracted as rutin and then hydrolyzed.
Researched mechanisms
The following are mechanisms reported in published laboratory and animal research — provided for formulation context, not as product claims.
- Studied for modulation of NF-κB and lipoxygenase pathways in cell models
- Studied for modulation of mast-cell degranulation and histamine release in cell models
- Studied for inhibition of xanthine oxidase in assay systems
- Studied for scavenging of reactive oxygen species via direct radical interaction and metal chelation in assay systems
Studied intake ranges
Published human studies have used quercetin in the 500–1000 mg/day range, with some trials using 1000 mg twice daily for up to 12 weeks. These are research figures for formulation context only — they are not dosing recommendations. Validate any finished-product intake level and labeling against the regulatory framework of your target market.
Co-formulation with vitamin C or bromelain, and administration with food, are common approaches in commercial formulations to support absorption.
Bioavailability strategies
Raw aglycone quercetin has bioavailability around 1%. Formulation options to improve this:
- Phytosome (lecithin–quercetin complex) — 5–20× higher Cmax than aglycone
- EMIQ (enzymatically modified isoquercitrin) — water-soluble glycoside, much higher absorption
- Cyclodextrin inclusion — improves solubility
- Co-administration with vitamin C — regenerates oxidized quercetin
Regulatory & safety
- US FDA: GRAS as a flavoring agent at low levels; for supplement use, falls under DSHEA. No drug claims allowed
- EFSA: not a Novel Food; ingredient considered to have a history of safe use
- LD₅₀ in mice >2 g/kg (oral); long-term human dosing at 1000 mg/day twice daily has been generally well tolerated for up to 12 weeks 1
Bulk-buying qualification
- Purity by HPLC — request COA with HPLC trace showing 95% or 98% quercetin (not just total flavonoid)
- Source documentation — Sophora japonica vs onion-derived: affects allergen profile and labeling
- Anhydrous vs dihydrate — anhydrous purity is calculated differently; clarify on COA
- Heavy metals, microbial, solvent residues — same diligence as any flavonoid
- For bioavailability-enhanced forms — separate qualification (phytosome ratio, EMIQ glycoside profile)
Get a quote from GreeneryBio →
References
Footnotes
-
Andres S et al. (2018). Safety aspects of quercetin as a dietary supplement. Mol Nutr Food Res. doi:10.1002/mnfr.201700447 ↩
